Page last updated: 2024-08-26

equol and Neuroectodermal Tumors, Primitive

equol has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belcher, SM; Burton, CC; Cookman, CJ; Kirby, M; Miranda, GL; Saeed, FO; Wray, KE	1

Other Studies

1 other study(ies) available for equol and Neuroectodermal Tumors, Primitive

Article	Year
Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity. BMC pharmacology & toxicology, 2017, 09-06, Volume: 18, Issue:1 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Equol; Estradiol; Estrogens; Genistein; Glycine max; Humans; Isoflavones; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine	2017

Article

Year

Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.

BMC pharmacology & toxicology, 2017, 09-06, Volume: 18, Issue:1

Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Equol; Estradiol; Estrogens; Genistein; Glycine max; Humans; Isoflavones; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine

2017